Canton Strategic Holdings (CNTN) Total Liabilities (2020 - 2026)
Canton Strategic Holdings (CNTN) posted Total Liabilities of $114.9 million for Q1 2026, down 5.25% on a QoQ basis from $121.2 million in Q4 2025, and up 4538.81% year-over-year from $2.5 million in Q1 2025.
Canton Strategic Holdings (CNTN) Total Liabilities (2020 - 2026) Analysis & Trends
Canton Strategic Holdings' Total Liabilities history runs 7 years deep, the most recent figure standing at $114.9 million for Q1 2026.
- Quarterly Total Liabilities rose 4538.81% year-over-year to $114.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $114.9 million (up 4538.81% YoY) and the FY2025 annual result came in at $121.2 million, up 4921.6% from the prior year.
- Total Liabilities was $114.9 million for Q1 2026 at Canton Strategic Holdings, down from $121.2 million in the prior quarter.
- Across five years, Total Liabilities topped out at $121.2 million in Q4 2025 and bottomed at $902348.0 in Q3 2022.
- A 5-year average of $15.4 million and a median of $1.8 million in 2022 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities sank 78.42% — and 2025, when it jumped 4921.6%.
- Canton Strategic Holdings' Total Liabilities stood at $1.1 million in 2022, then surged by 58.52% to $1.8 million in 2023, then jumped by 33.0% to $2.4 million in 2024, then soared by 4921.6% to $121.2 million in 2025, then dropped by 5.25% to $114.9 million in 2026.
- Business Quant data shows CNTN's Total Liabilities at $114.9 million in Q1 2026, $121.2 million in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | Canton Strategic Holdings | 427.87 Mn | 427.87 Mn | - | 114.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 114.86 Mn |
| Dec 31, 2025 | 121.22 Mn |
| Sep 30, 2025 | 1.54 Mn |
| Jun 30, 2025 | 2.16 Mn |
| Mar 31, 2025 | 2.48 Mn |
| Dec 31, 2024 | 2.41 Mn |
| Sep 30, 2024 | 2.23 Mn |
| Jun 30, 2024 | 1.56 Mn |
| Mar 31, 2024 | 1.84 Mn |
| Dec 31, 2023 | 1.82 Mn |
| Sep 30, 2023 | 1.41 Mn |
| Jun 30, 2023 | 1.53 Mn |
| Mar 31, 2023 | 1.52 Mn |
| Dec 31, 2022 | 1.14 Mn |
| Sep 30, 2022 | 902,348.00 |
| Jun 30, 2022 | 1.21 Mn |
| Mar 31, 2022 | 1.75 Mn |
| Dec 31, 2021 | 5.31 Mn |
| Dec 31, 2020 | 4.01 Mn |